Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand

被引:140
作者
Khanolkar, AD
Abadji, V
Lin, SY
Hill, WAG
Taha, G
Abouzid, K
Meng, ZX
Fan, PS
Makriyannis, A
机构
[1] UNIV CONNECTICUT, DEPT PHARMACEUT SCI, STORRS, CT 06269 USA
[2] UNIV CONNECTICUT, DEPT MOL & CELL BIOL, STORRS, CT 06269 USA
[3] UNIV CONNECTICUT, INST SCI MAT, STORRS, CT 06269 USA
关键词
D O I
10.1021/jm960152y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Several analogs of an endogenous cannabimimetic, arachidonylethanolamide (anandamide), were synthesized to study the structural requirements of the ethanolamide head receptor affinities of the analogs were evaluated by a standard receptor binding assay using tritiated CP-55,940 as the radioligand and compared to anandamide which was shown to have a K-i of 78 nM. Replacement of the amide carbonyl oxygen by a sulfur atom had a detrimental effect on the CB1 affinity. The thio analogs of both anandamide and (R)-methanandamide showed very weak affinity for CB1. The secondary nature of the amidic nitrogen was also shown to be important for affinity, indicating a possible hydrogen-bonding interaction between the amide NH and the receptor. Introduction of a phenolic moiety in the head group resulted in the loss of receptor affinity except when a methylene spacer was introduced between the amidic nitrogen and the phenol. A select group of analogs were also tested for their affinity for the CB2 receptor using a mouse spleen preparation and were found to possess low affinities for the CB2 sites. Notably, anandamide and (R)-methanandamide demonstrated high selectivity for the CB1 receptor. Overall, the data presented here show that structural requirements of the head group of anandamide are rather stringent.
引用
收藏
页码:4515 / 4519
页数:5
相关论文
共 31 条
[1]   (R)-METHANANDAMIDE - A CHIRAL NOVEL ANANDAMIDE POSSESSING HIGHER POTENCY AND METABOLIC STABILITY [J].
ABADJI, V ;
LIN, SY ;
TAHA, G ;
GRIFFIN, G ;
STEVENSON, LA ;
PERTWEE, RG ;
MAKRIYANNIS, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (12) :1889-1893
[2]  
ADAMS IB, 1995, J PHARMACOL EXP THER, V273, P1172
[3]   PHARMACOLOGICAL AND BEHAVIORAL-EVALUATION OF ALKYLATED ANANDAMIDE ANALOGS [J].
ADAMS, IB ;
RYAN, W ;
SINGER, M ;
RAZDAN, RK ;
COMPTON, DR ;
MARTIN, BR .
LIFE SCIENCES, 1995, 56 (23-24) :2041-2048
[4]   5'-AZIDO-DELTA-8-THC - A NOVEL PHOTOAFFINITY LABEL FOR THE CANNABINOID RECEPTOR [J].
CHARALAMBOUS, A ;
GUO, Y ;
HOUSTON, DB ;
HOWLETT, AC ;
COMPTON, DR ;
MARTIN, BR ;
MAKRIYANNIS, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (16) :3076-3079
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]  
DEUTSCH D, IN PRESS NIDA RES MO
[7]   ENZYMATIC-SYNTHESIS AND DEGRADATION OF ANANDAMIDE, A CANNABINOID RECEPTOR AGONIST [J].
DEUTSCH, DG ;
CHIN, SA .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (05) :791-796
[8]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[9]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[10]   A RAPID METHOD FOR PREPARING SYNAPTOSOMES - COMPARISON, WITH ALTERNATIVE PROCEDURES [J].
DODD, PR ;
HARDY, JA ;
OAKLEY, AE ;
EDWARDSON, JA ;
PERRY, EK ;
DELAUNOY, JP .
BRAIN RESEARCH, 1981, 226 (1-2) :107-118